Literature DB >> 24615722

Distinct differences in clinical manifestation and viral laboratory parameters between children and adults with influenza A(H1N1)pdm09 infection--a retrospective comparative analysis.

Monika Redlberger-Fritz1, Sonja Hirk, Dieter Buchinger, Renate Haberl, Markus Hell, Nicole Perkmann-Nagele, Michael Kundi, Therese Popow-Kraupp.   

Abstract

During the influenza pandemic 2009 children and adults differed in the clinical course of the influenza disease. In following the question arose, if the case definitions used within the national and international organizations are an adequate tool for the clinical diagnosis of influenza in children as well as in adults. Therefore medical charts from 146 children and 229 adults were retrospectively analyzed. In addition, the initial viral loads of all 375 patients and the duration of virus shedding of a subset of 79 patients were also investigated. Children show a wider clinical spectrum including gastro enteric symptoms and also a different spectrum of laboratory parameters like elevated CRP-levels, leucocytosis, and higher viral loads. Further, children show significantly more often complications, for example, myositis that may be underdiagnosed. In patients receiving antiviral-therapy complications occurred significantly less often and the presence of symptoms was significantly shorter compared to the untreated group (2.3 days vs. 6.0 days). In summary, the differences in the clinical picture between children and adults should be taken into consideration for the clinical diagnosis of influenza and also for a future discussion on age specific influenza case definitions.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  antiviral therapy; clinical manifestations; comparative analysis; differences between children and adults; influenza A(H1N1)pdm09 virus; viral laboratory parameters

Mesh:

Substances:

Year:  2014        PMID: 24615722     DOI: 10.1002/jmv.23912

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  6 in total

1.  Predictors of Influenza Diagnosis Among Patients With Laboratory-Confirmed Influenza.

Authors:  Marc R Miller; Timothy R Peters; Cynthia K Suerken; Beverly M Snively; Katherine A Poehling
Journal:  J Infect Dis       Date:  2015-05-04       Impact factor: 5.226

Review 2.  Viral Infection in the Development and Progression of Pediatric Acute Respiratory Distress Syndrome.

Authors:  Steven Nye; Richard J Whitley; Michele Kong
Journal:  Front Pediatr       Date:  2016-11-24       Impact factor: 3.418

3.  Evaluation of the point-of-care Becton Dickinson Veritor™ Rapid influenza diagnostic test in Kenya, 2013-2014.

Authors:  Linus K Ndegwa; Gideon Emukule; Timothy M Uyeki; Eunice Mailu; Sandra S Chaves; Marc-Alain Widdowson; Bandika V Lewa; Francis K Muiruri; Peter Omoth; Barry Fields; Joshua A Mott
Journal:  BMC Infect Dis       Date:  2017-01-11       Impact factor: 3.090

4.  Characteristics of hospitalised patients with influenza in 2015-2016 in northern Israel: three circulating strains and continued fear of 2009 A/H1N1.

Authors:  Tomer Kalish; Dan Miron; Maya Azrad; Hagai Rechnitzer; Hila Ben-Amram; Daniel Glikman; Avi Peretz
Journal:  Epidemiol Infect       Date:  2019-09-25       Impact factor: 2.451

Review 5.  Secondary myopathy due to systemic diseases.

Authors:  J Finsterer; W N Löscher; J Wanschitz; S Quasthoff; W Grisold
Journal:  Acta Neurol Scand       Date:  2016-02-25       Impact factor: 3.209

Review 6.  Immunotherapeutic Challenges for Pediatric Cancers.

Authors:  Brian Hutzen; Mohammed Ghonime; Joel Lee; Elaine R Mardis; Ruoning Wang; Dean A Lee; Mitchell S Cairo; Ryan D Roberts; Timothy P Cripe; Kevin A Cassady
Journal:  Mol Ther Oncolytics       Date:  2019-08-28       Impact factor: 7.200

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.